These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 20819543)

  • 21. Has the symptom severity inclusion requirement narrowed the definition of major depressive disorder in antidepressant efficacy trials?
    Zimmerman M; Walsh E; Chelminski I; Dalrymple K
    J Affect Disord; 2017 Mar; 211():60-64. PubMed ID: 28088058
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Early reduction in painful physical symptoms is associated with improvements in long-term depression outcomes in patients treated with duloxetine.
    Schneider E; Linden M; Weigmann H; Wagner T; Quail D; Hundemer HP; Hegerl U
    BMC Psychiatry; 2011 Sep; 11():150. PubMed ID: 21933428
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Real-world outcomes in patients with depression treated with duloxetine or a selective serotonin reuptake inhibitor in East Asia.
    Hong J; Novick D; Montgomery W; Moneta MV; Dueñas H; Peng X; Haro JM
    Asia Pac Psychiatry; 2016 Mar; 8(1):51-9. PubMed ID: 25808275
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Duloxetine in the acute and long-term treatment of major depressive disorder: a placebo- and paroxetine-controlled trial.
    Detke MJ; Wiltse CG; Mallinckrodt CH; McNamara RK; Demitrack MA; Bitter I
    Eur Neuropsychopharmacol; 2004 Dec; 14(6):457-70. PubMed ID: 15589385
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The impacts of migraine and anxiety disorders on painful physical symptoms among patients with major depressive disorder.
    Hung CI; Liu CY; Chen CY; Yang CH; Wang SJ
    J Headache Pain; 2014 Nov; 15(1):73. PubMed ID: 25382691
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Painful physical symptoms and treatment outcome in major depressive disorder: a STAR*D (Sequenced Treatment Alternatives to Relieve Depression) report.
    Leuchter AF; Husain MM; Cook IA; Trivedi MH; Wisniewski SR; Gilmer WS; Luther JF; Fava M; Rush AJ
    Psychol Med; 2010 Feb; 40(2):239-51. PubMed ID: 19493369
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Which somatic symptoms are associated with an unfavorable course in Asian patients with major depressive disorder?
    Novick D; Montgomery W; Aguado J; Kadziola Z; Peng X; Brugnoli R; Haro JM
    J Affect Disord; 2013 Jul; 149(1-3):182-8. PubMed ID: 23521872
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Results of the French cohort of the European observational study FINDER: quality of life of patients treated with antidepressants].
    Dantchev N; Tcherny-Lessenot S; Picard H; Baraille L; Quail D
    Encephale; 2013 Apr; 39(2):101-8. PubMed ID: 23095580
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Painful physical symptoms and antidepressant treatment outcome in depression: a systematic review and meta-analysis.
    Liu JJ; Huang X; Bao YP; Lu L; Dong P; Wolkowitz OM; Kelsoe JR; Shi J; Wei YB
    Mol Psychiatry; 2024 Aug; 29(8):2560-2567. PubMed ID: 38480874
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relationship between major depressive disorder and associated painful physical symptoms: analysis of data from two pooled placebo-controlled, randomized studies of duloxetine.
    Robinson MJ; Sheehan D; Gaynor PJ; Marangell LB; Tanaka Y; Lipsius S; Ohara F; Namiki C
    Int Clin Psychopharmacol; 2013 Nov; 28(6):330-8. PubMed ID: 23873291
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Importance of remission and residual somatic symptoms in health-related quality of life among outpatients with major depressive disorder: a cross-sectional study.
    Woo JM; Jeon HJ; Noh E; Kim HJ; Lee SW; Lee KK; Kim SH; Hong JP
    Health Qual Life Outcomes; 2014 Dec; 12():188. PubMed ID: 25519704
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Early vs. conventional switching of antidepressants in patients with MDD and moderate to severe pain: a double-blind randomized study.
    Romera I; Pérez V; Menchón JM; Schacht A; Papen R; Neuhauser D; Abbar M; Picard H; Gilaberte I
    J Affect Disord; 2012 Dec; 143(1-3):47-55. PubMed ID: 22858211
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Is duloxetine's effect on painful physical symptoms in depression an indirect result of improvement of depressive symptoms? Pooled analyses of three randomized controlled trials.
    Harada E; Tokuoka H; Fujikoshi S; Funai J; Wohlreich MM; Ossipov MH; Iwata N
    Pain; 2016 Mar; 157(3):577-584. PubMed ID: 26882344
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antidepressant medication treatment patterns in Asian patients with major depressive disorder.
    Novick D; Montgomery W; Moneta V; Peng X; Brugnoli R; Haro JM
    Patient Prefer Adherence; 2015; 9():421-8. PubMed ID: 25792815
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Association between health related quality of life and severity of depression in patients with major depressive disorder].
    Cao Y; Li W; Shen J; Zhang Y
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2011 Feb; 36(2):143-8. PubMed ID: 21368424
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Once-daily duloxetine 60 mg in the treatment of major depressive disorder: multicenter, double-blind, randomized, paroxetine-controlled, non-inferiority trial in China, Korea, Taiwan and Brazil.
    Lee P; Shu L; Xu X; Wang CY; Lee MS; Liu CY; Hong JP; Ruschel S; Raskin J; Colman SA; Harrison GA
    Psychiatry Clin Neurosci; 2007 Jun; 61(3):295-307. PubMed ID: 17472599
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An observational study of duloxetine versus SSRI monotherapy in Japanese patients with major depressive disorder: subgroup analyses of treatment effectiveness for pain, depressive symptoms, and quality of life.
    Kuga A; Tsuji T; Hayashi S; Fujikoshi S; Tokuoka H; Yoshikawa A; Escobar R; Tanaka K; Azekawa T
    Neuropsychiatr Dis Treat; 2017; 13():2115-2124. PubMed ID: 28831260
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy and safety of duloxetine 60 mg once daily in the treatment of pain in patients with major depressive disorder and at least moderate pain of unknown etiology: a randomized controlled trial.
    Brecht S; Courtecuisse C; Debieuvre C; Croenlein J; Desaiah D; Raskin J; Petit C; Demyttenaere K
    J Clin Psychiatry; 2007 Nov; 68(11):1707-16. PubMed ID: 18052564
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Factors related to the improvement in quality of life for depressed inpatients treated with fluoxetine.
    Yang WC; Lin CH; Wang FC; Lu MJ
    BMC Psychiatry; 2017 Aug; 17(1):309. PubMed ID: 28841824
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy and Safety of Agomelatine vs Paroxetine Hydrochloride in Chinese Han Patients with Major Depressive Disorder: A Multicentre, Double-Blind, Noninferiority, Randomized Controlled Trial.
    Yu YM; Gao KR; Yu H; Shen YF; Li HF
    J Clin Psychopharmacol; 2018 Jun; 38(3):226-233. PubMed ID: 29620692
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.